Yen‐Ming Hsu

3.9k total citations · 2 hit papers
36 papers, 3.1k citations indexed

About

Yen‐Ming Hsu is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yen‐Ming Hsu has authored 36 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 12 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Yen‐Ming Hsu's work include T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). Yen‐Ming Hsu is often cited by papers focused on T-cell and B-cell Immunology (16 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). Yen‐Ming Hsu collaborates with scholars based in United States, Switzerland and Germany. Yen‐Ming Hsu's co-authors include Christopher D. Benjamin, Roy R. Lobb, Theresa M. Palabrica, Mark Aronovitz, Bruce Furie, Barbara C. Furie, Yves Chicheportiche, Haoda Xu, Jeffrey L. Browning and Hamish S. Scott and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Yen‐Ming Hsu

35 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets

1992 661 citations Theresa M. Palabrica, Roy R. Lobb et al. Nature profile →
TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis

1997 563 citations Yves Chicheportiche, P Bourdon et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Yen‐Ming Hsu

Since Specialization

Citations

This map shows the geographic impact of Yen‐Ming Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Ming Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Ming Hsu more than expected).

Fields of papers citing papers by Yen‐Ming Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Ming Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Ming Hsu. The network helps show where Yen‐Ming Hsu may publish in the future.

Co-authorship network of co-authors of Yen‐Ming Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Ming Hsu. A scholar is included among the top collaborators of Yen‐Ming Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Ming Hsu. Yen‐Ming Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blockade of IgG Fc receptors reduces pain after intervertebral disc injury 2025 ·Pharmacological Reports ·(unknown), Peyman Sahbaie, Tian Z. Guo, Yen‐Ming Hsu, Wade S. Kingery, James D. Clark	1
2	Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants 2022 ·Frontiers in Immunology ·(unknown), Sanjucta Dutta, Ai‐ris Y. Collier, Jeng-Shin Lee, Yen‐Ming Hsu, Qiao Wang, (unknown), (unknown), Haohai Zhang, Lili Feng, Simon C. Robson, Wenda Gao, Stefan Riedel	3
3	Aberrant Expression of Functional BAFF-System Receptors by Malignant B-Cell Precursors Impacts Leukemia Cell Survival 2011 ·PLoS ONE ·(unknown), Marc R. Pelletier, Jixin Ding, Yen‐Ming Hsu, (unknown), Sambasiva P. Rao, Lee M. Nadler, Angelo A. Cardoso	38
4	Development of an Fn14 agonistic antibody as an anti-tumor agent 2011 ·mAbs ·Jennifer S. Michaelson, Aldo Amatucci, Rebecca K. Kelly, Lihe Su, Ellen A. Garber, Eric S. Day, (unknown), (unknown), You Li, Michael Parr, (unknown), Pascal Schneider, Kathleen Wortham, Linda C. Burkly, Yen‐Ming Hsu, Ingrid B.J. Joseph	38
5	Antagonism of TIM-1 blocks the development of disease in a humanized mouse model of allergic asthma 2010 ·Journal of Clinical Investigation ·(unknown), Yen‐Ming Hsu, Melanie L. Conrad, Gerard R. Majeau, Ayşe Kılıç, Ellen A. Garber, Yan Gao, (unknown), (unknown), Jan C. Dudda, (unknown), Véronique Bailly, Axel Pagenstecher, Paul D. Rennert, Harald Renz	34
6	An active CD8α/pMHCI interaction is required for CD8 single positive thymocyte differentiation 2009 ·European Journal of Immunology ·Yoon‐Joong Kang, Xiaosong Wang, (unknown), Yen‐Ming Hsu, Hsiu‐Ching Chang	2
7	CD8αβ Has Two Distinct Binding Modes of Interaction with Peptide-Major Histocompatibility Complex Class I 2006 ·Journal of Biological Chemistry ·Hsiu‐Ching Chang, Kemin Tan, Yen‐Ming Hsu	13
8	Tweak induces mammary epithelial branching morphogenesis 2005 ·Oncogene ·Jennifer S. Michaelson, (unknown), Beth Browning, Timothy S. Zheng, John Lincecum, Monica Z. Wang, Yen‐Ming Hsu, Linda C. Burkly	73
9	The Biochemistry and Biology of BAFF, APRIL and Their Receptors 2004 ·PubMed ·Susan L. Kalled, Christine Ambrose, Yen‐Ming Hsu	63
10	Comparison of Soluble Decoy IgG Fusion Proteins of BAFF-R and BCMA as Antagonists for BAFF 2003 ·Journal of Biological Chemistry ·Marc R. Pelletier, Jeffrey S. Thompson, Fang Qian, Sarah A. Bixler, (unknown), Teresa G. Cachero, Kevin Gilbride, Eric S. Day, Mohammad Zafari, (unknown), Leonid Gorelik, Adrian Whitty, Susan L. Kalled, Christine Ambrose, Yen‐Ming Hsu	79
11	Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) 2003 ·Journal of Biological Chemistry ·Pascal Schneider, Dian L. Olson, Aubry Tardivel, Beth Browning, Alexey A. Lugovskoy, (unknown), Max Dobles, Sylvie Hertig, Kay Hofmann, Herman van Vlijmen, Yen‐Ming Hsu, Linda C. Burkly, Jürg Tschopp, Timothy S. Zheng	101
12	Alefacept, an Immunomodulatory Recombinant LFA-3/IgG1 Fusion Protein, Induces CD16 Signaling and CD2/CD16-Dependent Apoptosis of CD2+ Cells 2002 ·The Journal of Immunology ·(unknown), Margot Brickelmaier, Gerard R. Majeau, Zhifang Li, Lihe Su, Yen‐Ming Hsu, Paula S. Hochman	99
13	Structure of CD40 Ligand in Complex with the Fab Fragment of a Neutralizing Humanized Antibody 2001 ·Structure ·Michael Karpusas, (unknown), Janine Ferrant, Christopher D. Benjamin, Frederick R. Taylor, Kathy Strauch, Ellen A. Garber, Yen‐Ming Hsu	41
14	CD154 Variant Lacking Tumor Necrosis Factor Homologous Domain Inhibits Cell Surface Expression of Wild-type Protein 2001 ·Journal of Biological Chemistry ·Lihe Su, Ellen A. Garber, Yen‐Ming Hsu	3
15	CD154 Variants Associated with Hyper-IgM Syndrome Can Form Oligomers and Trigger CD40-mediated Signals 1999 ·Journal of Biological Chemistry ·Ellen A. Garber, Lihe Su, Barbara Ehrenfels, (unknown), Yen‐Ming Hsu	20
16	The role of polar interactions in the molecular recognition of CD40L with its receptor CD40 1998 ·Protein Science ·Juswinder Singh, Ellen A. Garber, Herman van Vlijmen, Michael Karpusas, Yen‐Ming Hsu, (unknown), David W. Thomas, James H. Naismith	60
17	Heteromultimeric Complexes of CD40 Ligand Are Present on the Cell Surface of Human T Lymphocytes 1997 ·Journal of Biological Chemistry ·Yen‐Ming Hsu, (unknown), Lihe Su, Barbara Ehrenfels, Ellen A. Garber, David W. Thomas	47
18	TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis breakdown → 1997 ·Journal of Biological Chemistry ·Yves Chicheportiche, P Bourdon, Haoda Xu, Yen‐Ming Hsu, Hamish S. Scott, Catherine Hession, Irène Garcia, Jeffrey L. Browning	563
19	2 å crystal structure of an extracellular fragment of human CD40 ligand 1995 ·Structure ·Michael Karpusas, Yen‐Ming Hsu, Jia‐Huai Wang, Jeff Thompson, Seth Lederman, Leonard Chess, David W. Thomas	195
20	Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets breakdown → 1992 ·Nature ·Theresa M. Palabrica, Roy R. Lobb, Barbara C. Furie, Mark Aronovitz, Christopher D. Benjamin, Yen‐Ming Hsu, (unknown), Bruce Furie	661

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact